Globus Medical Inc. Class A Common Stock vs Home Depot Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Home Depot Inc trades at $298.79 (market cap $294.83B). The key difference: Home Depot Inc is far larger — about 28.8× Globus Medical Inc. Class A Common Stock's market cap, and Home Depot Inc pays a 3.15% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Home Depot Inc for 139 Days on average.
| GMED | HD | |
|---|---|---|
Market Cap | $10.25B | $294.83B |
Volume | 1,059,528 | 4,653,976 |
Sector | Health | Consumer Cyclical |
52-Week High | $96.82 | $391.90 |
52-Week Low | $58.33 | $281.15 |
Typical Hold Time | 0 Days | 139 Days |
Enterprise Value | $9.76B | $355.31B |
Dividend Yield | — | 3.15% |
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Home Depot (HD) trades at $293.92, up 1.14% with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 33.21% gross margins and 104.3% ROE, though net margins have declined from 10.87% in 2022 to 8.41% currently. Analyst consensus remains bullish with a $379.93 price target, representing 29% upside potential from current levels. Recent institutional activity shows mixed sentiment with both acquisitions and reductions in holdings.
HD faces near-term headwinds from weakening big-ticket demand and margin pressure, but strong Pro business and housing tailwinds support long-term growth. The stock's current valuation at 20.57 P/E appears reasonable relative to historical levels. Key risks include rising mortgage rates impacting housing activity and competitive pressures in home improvement retail.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →